Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis
Journal of Gastroenterology and Hepatology · 2024-12 · 39 (12) · 2545-2554
DOI: 10.1111/jgh.16723 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 16.08.2024. Verfasst von Nicholas Ming-Zher Chee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Alanine Transaminase, Aspartate Aminotransferases, Biomarkers, Fatty Liver. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Multiple clinical trials have been conducted to study the potential benefits of vitamin E for the treatment of metabolic dysfunction‐associated steatotic liver disease (MASLD). Despite available evidence, vitamin E is not widely used. This study aimed to assess the effect of vitamin E on serum markers of liver inflammation, specifically serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, and histology, including resolution of metabolic dysfunction‐associated steatohepatitis (MASH), in adult patients with MASLD.
Methods
A systematic literature search on randomized controlled trials published in English was conducted using electronic databases. Standardized mean difference (SMD) and mean difference (MD) were used for continuous outcomes, while risk ratio (RR) was used for dichotomous outcomes, with corresponding 95% confidence interval (CI).
Results
A total of eight studies were included in the qualitative synthesis while seven studies were included in the meta‐analysis. Vitamin E significantly reduced serum ALT and AST levels with SMD of −0.82 (95% CI, −1.13 to −0.51) and −0.68 (95% CI, −0.94 to −0.41), respectively. Vitamin E significantly reduced steatosis, lobular inflammation, and hepatocyte ballooning with a MD of −0.60 (95% CI, −0.83 to −0.37), −0.34 (95% CI, −0.53 to −0.16), −0.32 (95% CI, −0.53 to −0.12), and increased MASH resolution with a RR of 1.9 (95%CI, 1.20 to 3.02). However, vitamin E did not reduce fibrosis, with a MD of −0.23 (95% CI, −0.51 to 0.05).
Conclusion
Vitamin E resulted in significant improvement in serum markers of liver inflammation and histology in patients with MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
ORCID-Profile: Nicholas Ming-Zher Chee, Ram Prasad Sinnanaidu, Wah-Kheong Chan
Zitieren
APA
Chee, N. M., Sinnanaidu, R. P., & Chan, W. K. (2024). Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology, 39(12), 2545-2554. https://doi.org/10.1111/jgh.16723
Vancouver
Chee NM, Sinnanaidu RP, Chan WK. Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 2024;39(12):2545-2554. doi:10.1111/jgh.16723
BibTeX
@article{Chee2024,
author = {Chee, Nicholas Ming-Zher and Sinnanaidu, Ram Prasad and Chan, Wah-Kheong},
title = {Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
volume = {39},
number = {12},
pages = {2545--2554},
doi = {10.1111/jgh.16723}
}
EUVIMED